Citation tools

Lee, Kevin et al "CRT-600.05 Eligibility for PCSK9 Inhibitor Treatment in 1090 Hypercholesterolemic Patients Referred to a Regional Cholesterol Treatment Center with LDL Cholesterol >=70 mg/dl Despite Maximal Tolerated Cholesterol Lowering Therapy." JACC: Cardiovascular Interventions 10.3 Supplement (2017): S53. Web. 19 May. 2019.
Advertisement